PAR 1.92% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2485

  1. 278 Posts.
    lightbulb Created with Sketch. 107
    Well I hope you're wrong, but I suspect you might well be right.
    In my view we've got 10 out of 10 for the product, 6 out of 10 for our IP, and about 3 out of 10 for our management team.
    When CEOs over-promise, and then under-deliver they lose credibility with existing and potential investors - how hard is that for them to understand?
    I hope we get a new CEO very soon, and that the first thing he or she does is to clear the decks, and get any bad news or internal concerns out there on Day 1. Because right now I have close to zero confidence that there's not yet another piece of bad news just around the corner.
    And in my view this is why our share price is in the toilet - nothing to do with shorters or downrampers - just a lack of investor confidence in management.
    My views only - DYOR. GLTAH.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $92.69M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $233.3K 883.2K

Buyers (Bids)

No. Vol. Price($)
1 18279 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 662 1
View Market Depth
Last trade - 14.51pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.